Advertisement

Topics

Clinical Trials About "Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus" RSS

09:07 EDT 20th March 2019 | BioPortfolio

We list hundreds of Clinical Trials about "Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.

More Information about "Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus" on BioPortfolio

We have published hundreds of Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus news stories on BioPortfolio along with dozens of Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus Clinical Trials and PubMed Articles about Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus Companies in our database. You can also find out about relevant Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus Drugs and Medications on this site too.

Showing "Safety Efficacy Study EGT0001442 Subjects With Type Diabetes" Clinical Trials 1–25 of 55,000+

Extremely Relevant

Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus

The purpose of this study is to assess the effect of EGT0001442 on fasting plasma glucose after 28 days of treatment in subjects with type 2 diabetes. The study will also assess the pharmacokinetics (how much of the drug gets into the blood and how long it takes the body to get rid of it), safety and tolerability of EGT0001442, the effect on weight and HbA1c as well as the effect EGT0001442 has on the amount of glucose produced in the body by the urine.


Relevant

A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.

The study is being conducted to evaluate the efficacy and safety of Noiiglutide Injection as mono-therapy with different doses in subjects with type 2 diabetes compared to placebo for 16 weeks.

Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes Mellitus

The purpose of this study is to determine the efficacy and safety of SYR-619, once daily (QD), in subjects with type 2 diabetes mellitus who have not achieved glycemic control with diet and exercise, or by taking metformin.


Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II Diabetes

The aim of this pilot study is to assess the safety and preliminary efficacy of 5-ALA - SFC at doses up to 200 mg per day in subjects with type II diabetes.

A Study to Evaluate Safety and Efficacy of PHX1149T in Subjects With Type 2 Diabetes Mellitus

This study is to test the efficacy and safety of PHX1149T in combination with metformin, a glitazone, or metformin and a glitazone in subjects with Type 2 diabetes for 12 weeks. After completing the 12 week double blind part of the study, subjects can enter an open label extension study

Study of ITCA 650 in Subjects With Type 2 Diabetes Mellitus

The purpose of this study is to determine safety, efficacy and tolerability of various doses of ITCA 650 in subjects with type 2 diabetes.

A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes

The purpose of this study is to evaluate the efficacy and safety of adding Symlin to an established regimen of insulin glargine in subjects with type 2 diabetes who are not achieving glycemic targets.

Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy

The study hypothesis is that XOMA 052 improves glycemic control in subjects with Type 2 Diabetes. Study X052078 is designed to establish efficacious dose(s) for future studies based on improvement in HbA1c.

A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes

This trial is a multi-center, randomized, double-blind, placebo-controlled parallel group, Phase 2 study in subjects with Type 2 diabetes mellitus on a stable dose of metformin to evaluate the safety and efficacy of TTP273 versus placebo glucose control and body weight following administration for 3 months.

Study of EndoBarrier Liner for Treatment of Type 2 Diabetes Study

The main objective of the study is to demonstrate the safety and efficacy of the Gastrointestinal (GI) EndoBarrier in the glycemic control of diabetes in subjects with Type 2 diabetes.

A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes

This is a double-blind, randomized, placebo-controlled, parallel-group comparison study to evaluate the efficacy and safety of Cyclo-Z vs. placebo in adult subjects with type 2 diabetes. Approximately 20 clinical sites may be utilized in the United States so that approximately 300 subjects (a potential 20% screening failure rate) may be screened for total 28-week study period (2 weeks for screening, 24 weeks for treatment, and 2 weeks for safety follow-up).

Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus

The purpose of this study is to determine the efficacy and safety of SYR-472, once daily (QD), in subjects with type 2 diabetes mellitus who have not achieved glycemic control with diet and exercise, or by taking metformin.

Efficacy of DLBS-32 in Subjects With Type-II Diabetes Mellitus

The purpose of this study is to investigate clinical efficacy and safety of DLBS 32 in the management of subjects with type-II-diabetes mellitus and to determine the minimal effective dose of DLBS 32 for subjects with type-II-diabetes mellitus.

A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.

This randomized, double-blind, active-controlled study evaluates the efficacy and safety of a weekly dose of albiglutide as compared with sitagliptin. Subjects who are renally impaired with a historical diagnosis of type 2 diabetes mellitus and whose glycemia is inadequately controlled on their current regimen of diet and exercise or their antidiabetic therapy of metformin, thiazolidinedione, sulfonylurea, or any combination of these oral antidiabetic medications will be recrui...

Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate Safety and Efficacy of PHX1149T as Monotherapy in Subjects with Type 2 Diabetes Mellitus

Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus

Ligand Pharmaceuticals Incorporated is developing LGD-6972, a novel, orally-bioavailable addition to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The mechanism of action of LGD-6972 is to reduce the excess liver glucose production characteristic of type 2 diabetes mellitus that is a major contributor to hyperglycemia. This clinical trial will evaluate the safety and tolerability of escalating doses LGD-6972 administered daily over 2 - 4...

Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.

The aim of this trial is to evaluate the efficacy and safety of insulin detemir using the 2400 nmol/mL formulation to optimise dosing in subjects with type 1 diabetes on a basal (once daily)-bolus regimen.

A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.

A Phase 2 study with two cohorts of differing doses designed to evaluate the efficacy, safety and pharmacokinetics (PK) of MEDI0382 in patients with Type 2 Diabetes Mellitus. Approximately 63 subjects will be enrolled across two cohorts.

Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.

The purpose of this study is to determine the safety and efficacy of alogliptin, once daily (QD), compared to diet and exercise, sulfonylurea, metformin and a combination of sulfonylurea and metformin for treating subjects with type 2 diabetes.

A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes.

A study to determine the safety and efficacy of albiglutide in subjects with type 2 diabetes.

Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes

The study is conducted in Asia. The aim of this observational study is to evaluate the weight change from baseline while using Levemir® in subjects with type 2 diabetes mellitus under normal clinical practice conditions in India.

Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus

The purpose of this study is to evaluate the safety and effectiveness of multiple doses of TAK-379, once daily (QD), in subjects with type 2 diabetes mellitus.

Efficacy and Safety of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

The purpose of this study was to determine the safety and efficacy of TAK-559, once daily (QD), in Type 2 Diabetes subjects.

Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese

To determine if the EndoBarrier safely and effectively improves glycemic control in obese subjects with type 2 diabetes

Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus

The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of XOMA 052 in subjects with stable Type 2 Diabetes Mellitus (T2D). It is hypothesized that administration of XOMA 052 is likely to improve glycemic control in subjects with T2D by blocking certain receptors.


More From BioPortfolio on "Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus"

Advertisement
Quick Search
Advertisement
Advertisement